Glivo M 0.2

Product Description

Glivo M 0.2 is a powerful combination of Voglibose (0.2 mg) Metformin (500 mg) and Gliclazide (80 mg) designed for the comprehensive management of type 2 diabetes mellitus. Voglibose works as an alpha-glucosidase inhibitor slowing down carbohydrate absorption in the intestines. Metformin enhances insulin sensitivity and decreases hepatic glucose production while Gliclazide stimulates insulin secretion from the pancreas. Together these ingredients provide a multi-faceted approach to blood sugar control helping patients achieve optimal glycemic levels and reduce the risk of complications associated with diabetes.